Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Zimmer Biomet Holdings, Inc. ZBH
$136.14
-$0.55 (-0.40%)
На 18:00, 12 мая 2023
+4.45%
Потенциал через год
Ранг: 2
Ключевые показатели
-
Marketcap
28577634570.00000000
-
week52high
149.25
-
week52low
100.39
-
Revenue
6939900000
-
P/E TTM
64
-
Beta
1.00207600
-
EPS
1.37000000
-
Last Dividend
0.96000000
-
Next Earnings Date
31 июл 2023 г. в 10:30
Описание компании
Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; spine products comprising medical devices and surgical instruments; and face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest toss facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers dental products that include dental reconstructive implants, and dental prosthetic and regenerative products, as well as robotic, surgical and bone cement products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, oral surgeons, dentists, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| Morgan Stanley | Equal-Weight | Equal-Weight | 03 авг 2022 г. |
| Stifel | Buy | Buy | 18 июл 2022 г. |
| Morgan Stanley | Equal-Weight | Equal-Weight | 15 июл 2022 г. |
| Needham | Hold | Buy | 27 мая 2022 г. |
| Citigroup | Neutral | Neutral | 17 мая 2022 г. |
| Barclays | Underweight | 18 окт 2022 г. | |
| Jefferies | Underperform | 12 окт 2022 г. | |
| RBC Capital | Sector Perform | Sector Perform | 03 ноя 2022 г. |
| Citigroup | Neutral | Neutral | 03 ноя 2022 г. |
| Wells Fargo | Equal-Weight | Underweight | 23 ноя 2022 г. |
| JP Morgan | Neutral | Neutral | 11 янв 2023 г. |
| RBC Capital | Outperform | Sector Perform | 09 янв 2023 г. |
| Morgan Stanley | Equal-Weight | Equal-Weight | 06 янв 2023 г. |
| Raymond James | Outperform | Market Perform | 05 янв 2023 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Покожие компании
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| BEGLEY CHRISTOPHER B | A | 16254 | 295 | 31 дек 2022 г. |
| BERNARD BETSY J | A | 17187 | 246 | 31 дек 2022 г. |
| Farrell Michael J. | A | 11735 | 246 | 31 дек 2022 г. |
| HAGEMANN ROBERT | A | 25423 | 266 | 31 дек 2022 г. |
| HIGGINS ARTHUR J | A | 30157 | 256 | 31 дек 2022 г. |
| Hilado Maria Teresa | A | 5961 | 217 | 31 дек 2022 г. |
| Jafry Syed A. | A | 4019 | 108 | 31 дек 2022 г. |
| Kolli Sreelakshmi | A | 1886 | 108 | 31 дек 2022 г. |
| MICHELSON MICHAEL W | A | 10532 | 217 | 31 дек 2022 г. |
| Phipps Chad F | D | 23045 | 11522 | 13 дек 2022 г. |
Institutional Ownership
Institutional Ownership
| Holder | Shares | Change | Date Reported |
|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 5825750 | -54200 | 31 авг 2020 г. |
| Vanguard 500 Index Fund | 4248460 | -17412 | 31 авг 2020 г. |
| SPDR S&P 500 ETF | 2157050 | -10375 | 31 авг 2020 г. |
| US Bank Vanguard Institutional 500 Index Trust | 1775980 | -9001 | 31 авг 2020 г. |
| CREF Stock Account | 2373020 | 195689 | 31 июл 2020 г. |
| Fidelity 500 Index Fund | 1842080 | -1994 | 31 июл 2020 г. |
| JPMorgan Mid Cap Value Fund | 1606840 | 0 | 31 июл 2020 г. |
| American Funds AMCAP Fund | 3826300 | 858000 | 30 июн 2020 г. |
| American Century Mid Cap Value Fund | 1773010 | -354412 | 30 июн 2020 г. |
| American Funds American Mutual Fund | 1657600 | 2300 | 30 июн 2020 г. |
Новостная лента
What Makes Zimmer Biomet (ZBH) a Strong Momentum Stock: Buy Now?
Zacks Investment Research
03 мая 2023 г. в 13:41
Does Zimmer Biomet (ZBH) have what it takes to be a top stock pick for momentum investors? Let's find out.
Zimmer Biomet (ZBH) Q1 Earnings Beat Estimates, View Raised
Zacks Investment Research
02 мая 2023 г. в 15:19
Each of Zimmer Biomet's (ZBH) geographic segments and product divisions records strong year-over-year sales growth at CER.
Zimmer Biomet (ZBH) Beats Q1 Earnings and Revenue Estimates
Zacks Investment Research
02 мая 2023 г. в 09:08
Zimmer Biomet (ZBH) came out with quarterly earnings of $1.89 per share, beating the Zacks Consensus Estimate of $1.66 per share. This compares to earnings of $1.61 per share a year ago.
ZBH or LMAT: Which Is the Better Value Stock Right Now?
Zacks Investment Research
26 апр 2023 г. в 12:54
Investors with an interest in Medical - Products stocks have likely encountered both Zimmer Biomet (ZBH) and LeMaitre Vascular (LMAT). But which of these two stocks offers value investors a better bang for their buck right now?
Zimmer Biomet (ZBH) Reports Next Week: Wall Street Expects Earnings Growth
Zacks Investment Research
25 апр 2023 г. в 11:28
Zimmer (ZBH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.